208 related articles for article (PubMed ID: 35684950)
1. In vitro antifungal susceptibility of Fusarium species and Aspergillus fumigatus cultured from eleven horses with fungal keratitis.
Martinez PS; Whitley RD; Plummer CE; Richardson RL; Hamor RE; Wellehan JFX
Vet Ophthalmol; 2022 Sep; 25(5):376-384. PubMed ID: 35684950
[TBL] [Abstract][Full Text] [Related]
2. In vitro susceptibility patterns of Aspergillus and Fusarium species isolated from equine ulcerative keratomycosis cases in the midwestern and southern United States with inclusion of the new antifungal agent voriconazole.
Pearce JW; Giuliano EA; Moore CP
Vet Ophthalmol; 2009; 12(5):318-24. PubMed ID: 19751493
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial susceptibility patterns of fungi isolated from horses with ulcerative keratomycosis.
Brooks DE; Andrew SE; Dillavou CL; Ellis G; Kubilis PS
Am J Vet Res; 1998 Feb; 59(2):138-42. PubMed ID: 9492925
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of antifungal susceptibility and clinical characteristics in fungal keratitis in a tertiary care center in North India.
Vanathi M; Naik R; Sidhu N; Ahmed NH; Gupta N; Tandon R
Indian J Ophthalmol; 2022 Dec; 70(12):4270-4283. PubMed ID: 36453329
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibility of Fusarium, Aspergillus, and other filamentous fungi isolated from keratitis.
Lalitha P; Shapiro BL; Srinivasan M; Prajna NV; Acharya NR; Fothergill AW; Ruiz J; Chidambaram JD; Maxey KJ; Hong KC; McLeod SD; Lietman TM
Arch Ophthalmol; 2007 Jun; 125(6):789-93. PubMed ID: 17562990
[TBL] [Abstract][Full Text] [Related]
6. In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial.
Lalitha P; Sun CQ; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Cevallos V; McLeod SD; Acharya NR; Lietman TM;
Am J Ophthalmol; 2014 Feb; 157(2):318-26. PubMed ID: 24439440
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Antifungal Resistance in Adult Patients With Fungal Keratitis in South India: A Post Hoc Analysis of 3 Randomized Clinical Trials.
Prajna NV; Lalitha P; Krishnan T; Rajaraman R; Radnakrishnan N; Srinivasan M; Devi L; Das M; Liu Z; Zegans ME; Acharya NR; Porco TC; Lietman TM; Rose-Nussbaumer J
JAMA Ophthalmol; 2022 Feb; 140(2):179-184. PubMed ID: 35024776
[TBL] [Abstract][Full Text] [Related]
8. In vitro susceptibility patterns of fungi associated with keratomycosis in horses of the northeastern United States: 68 cases (1987-2006).
Ledbetter EC; Patten VH; Scarlett JM; Vermeylen FM
J Am Vet Med Assoc; 2007 Oct; 231(7):1086-91. PubMed ID: 17916036
[TBL] [Abstract][Full Text] [Related]
9. Study of Pathogens of Fungal Keratitis and the Sensitivity of Pathogenic Fungi to Therapeutic Agents with the Disk Diffusion Method.
Wang L; Wang L; Han L; Yin W
Curr Eye Res; 2015; 40(11):1095-101. PubMed ID: 26268399
[TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Aspergillus and Fusarium associated with equine keratitis to new antifungal drugs.
Roberts D; Cotter HVT; Cubeta M; Gilger BC
Vet Ophthalmol; 2020 Sep; 23(5):918-922. PubMed ID: 32418311
[TBL] [Abstract][Full Text] [Related]
11. Multi-locus DNA sequence analysis, antifungal agent susceptibility, and fungal keratitis outcome in horses from Southeastern United States.
Cullen M; Jacob ME; Cornish V; VanderSchel IQ; Cotter HVT; Cubeta MA; Carbone I; Gilger BC
PLoS One; 2019; 14(3):e0214214. PubMed ID: 30921394
[TBL] [Abstract][Full Text] [Related]
12. Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of
Manikandan P; Abdel-Hadi A; Randhir Babu Singh Y; Revathi R; Anita R; Banawas S; Bin Dukhyil AA; Alshehri B; Shobana CS; Panneer Selvam K; Narendran V
Biomed Res Int; 2019; 2019():6395840. PubMed ID: 30800674
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the conjunctival fungal flora and its susceptibility to antifungal agents in healthy horses in Switzerland.
Voelter-Ratson K; Monod M; Unger L; Spiess BM; Pot SA
Vet Ophthalmol; 2014 Jul; 17 Suppl 1():31-6. PubMed ID: 23910390
[TBL] [Abstract][Full Text] [Related]
14. In vitro antifungal activity of silver nanoparticles against ocular pathogenic filamentous fungi.
Xu Y; Gao C; Li X; He Y; Zhou L; Pang G; Sun S
J Ocul Pharmacol Ther; 2013 Mar; 29(2):270-4. PubMed ID: 23410063
[TBL] [Abstract][Full Text] [Related]
15. Benefit of polyhexamethylene biguanide in Fusarium keratitis.
Behrens-Baumann W; Seibold M; Hofmüller W; Walter S; Haeberle H; Wecke T; Tammer I; Tintelnot K
Ophthalmic Res; 2012; 48(4):171-6. PubMed ID: 22710976
[TBL] [Abstract][Full Text] [Related]
16. In vitro synergy of natamycin and voriconazole against clinical isolates of
Sradhanjali S; Yein B; Sharma S; Das S
Br J Ophthalmol; 2018 Jan; 102(1):142-145. PubMed ID: 28982951
[TBL] [Abstract][Full Text] [Related]
17. Association between in vitro susceptibility to natamycin and voriconazole and clinical outcomes in fungal keratitis.
Sun CQ; Lalitha P; Prajna NV; Karpagam R; Geetha M; O'Brien KS; Oldenburg CE; Ray KJ; McLeod SD; Acharya NR; Lietman TM;
Ophthalmology; 2014 Aug; 121(8):1495-500.e1. PubMed ID: 24746358
[TBL] [Abstract][Full Text] [Related]
18. Impact of fungal species cultured on outcome in horses with fungal keratitis.
Sherman AB; Clode AB; Gilger BC
Vet Ophthalmol; 2017 Mar; 20(2):140-146. PubMed ID: 27061354
[TBL] [Abstract][Full Text] [Related]
19. Association of pretreatment with antifungal medication and fungal resistance in the mycotic ulcer treatment trial I.
Prajna NV; Prajna L; O'Brien KS; Sun CQ; Acharya N; Lietman TM; Rose-Nussbaumer J;
JAMA Ophthalmol; 2015 Oct; 133(10):1210-1. PubMed ID: 26110254
[No Abstract] [Full Text] [Related]
20. Necessity to identify the causative agent for appropriate treatment in fungal corneal ulcer: an in vitro study.
Gupta MK; Chandra A; Prakash P; Tilak R
J Mycol Med; 2018 Mar; 28(1):201-205. PubMed ID: 29398639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
